Gastrointestinal Stromal Tumor (GIST) Treatment Market Size, Share, Growth, and Regional Forecast, 2026 to 2033

Table of Content

1. Executive Summary
   1. Global Gastrointestinal Stromal Tumor (GIST) Treatment Market Snapshot, 2026 and 2033
   2. Market Opportunity Assessment, 2026 - 2033, US$ Mn
   3. Key Market Trends
   4. Future Market Projections
   5. Premium Market Insights
   6. Industry Developments and Key Market Events
   7. PMR Analysis and Recommendations
2. Market Overview
   1. Market Scope and Definition
   2. Market Dynamics
      1. Drivers
      2. Restraints
      3. Opportunity
      4. Challenges
      5. Key Trends
   3. Macro-Economic Factors
      1. Global Sectorial Outlook
      2. Global GDP Growth Outlook
   4. COVID-19 Impact Analysis
   5. Forecast Factors - Relevance and Impact
3. Value Added Insights
   1. Drug Adoption Analysis
   2. Regulatory Landscape
   3. Value Chain Analysis
   4. Key Deals and Mergers
   5. PESTLE Analysis
   6. Porter’s Five Force Analysis
4. Global Gastrointestinal Stromal Tumor (GIST) Treatment Market Outlook:
   1. Key Highlights
      1. Market Size (US$ Mn) and Y-o-Y Growth
      2. Absolute $ Opportunity
   2. Market Size (US$ Mn) Analysis and Forecast
      1. Historical Market Size (US$ Mn) Analysis, 2020-2024
      2. Market Size (US$ Mn) Analysis and Forecast, 2026-2033
   3. Global Gastrointestinal Stromal Tumor (GIST) Treatment Market Outlook: Drug
      1. Introduction / Key Findings
      2. Historical Market Size (US$ Mn) Analysis, By Drug, 2020 - 2024
      3. Market Size (US$ Mn) Analysis and Forecast, By Drug, 2026 - 2033
         1. Imatinib
         2. Ripretinib
         3. Crenolanib
         4. Regorafenib
         5. Avapritinib
         6. Sunitinib
         7. Others
      4. Market Attractiveness Analysis: Drug
   4. Global Gastrointestinal Stromal Tumor (GIST) Treatment Market Outlook: Treatment Type
      1. Introduction / Key Findings
      2. Historical Market Size (US$ Mn) Analysis, By Treatment Type, 2020 - 2024
      3. Market Size (US$ Mn) Analysis and Forecast, By Treatment Type, 2026 - 2033
         1. Targeted Therapy
         2. Immunotherapy
         3. Chemotherapy
         4. Surgery
      4. Market Attractiveness Analysis: Treatment Type
   5. Global Gastrointestinal Stromal Tumor (GIST) Treatment Market Outlook: Distribution Channel
      1. Introduction / Key Findings
      2. Historical Market Size (US$ Mn) Analysis, By Distribution Channel, 2020 - 2024
      3. Market Size (US$ Mn) Analysis and Forecast, By Distribution Channel, 2026 - 2033
         1. Hospital Pharmacies
         2. Retail Pharmacies
         3. Online Pharmacies
      4. Market Attractiveness Analysis: Distribution Channel
5. Global Gastrointestinal Stromal Tumor (GIST) Treatment Market Outlook: Region
   1. Key Highlights
   2. Historical Market Size (US$ Mn) Analysis, By Region, 2020 - 2024
   3. Market Size (US$ Mn) Analysis and Forecast, By Region, 2026 - 2033
      1. North America
      2. Europe
      3. East Asia
      4. South Asia and Oceania
      5. Latin America
      6. Middle East & Africa
   4. Market Attractiveness Analysis: Region
6. North America Gastrointestinal Stromal Tumor (GIST) Treatment Market Outlook:
   1. Key Highlights
   2. Historical Market Size (US$ Mn) Analysis, By Market, 2020 - 2024
      1. By Country
      2. By Drug
      3. By Treatment Type
      4. By Services
      5. By Distribution Channel
   3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2026 - 2033
      1. U.S.
      2. Canada
   4. Market Size (US$ Mn) Analysis and Forecast, By Drug, 2026 - 2033
      1. Imatinib
      2. Ripretinib
      3. Crenolanib
      4. Regorafenib
      5. Avapritinib
      6. Sunitinib
      7. Others
   5. Market Size (US$ Mn) Analysis and Forecast, By Treatment Type, 2026 - 2033
      1. Targeted Therapy
      2. Immunotherapy
      3. Chemotherapy
      4. Surgery
   6. Market Size (US$ Mn) Analysis and Forecast, By Distribution Channel, 2026 - 2033
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
   7. Market Attractiveness Analysis
7. Europe Gastrointestinal Stromal Tumor (GIST) Treatment Market Outlook:
   1. Key Highlights
   2. Historical Market Size (US$ Mn) Analysis, By Market, 2020 - 2024
      1. By Country
      2. By Drug
      3. By Treatment Type
      4. By Services
      5. By Distribution Channel
   3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2026 - 2033
      1. Germany
      2. France
      3. U.K.
      4. Italy
      5. Spain
      6. Russia
      7. Türkiye
      8. Rest of Europe
   4. Market Size (US$ Mn) Analysis and Forecast, By Drug, 2026 - 2033
      1. Imatinib
      2. Ripretinib
      3. Crenolanib
      4. Regorafenib
      5. Avapritinib
      6. Sunitinib
      7. Others
   5. Market Size (US$ Mn) Analysis and Forecast, By Treatment Type, 2026 - 2033
      1. Targeted Therapy
      2. Immunotherapy
      3. Chemotherapy
      4. Surgery
   6. Market Size (US$ Mn) Analysis and Forecast, By Distribution Channel, 2026 - 2033
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
   7. Market Attractiveness Analysis
8. East Asia Gastrointestinal Stromal Tumor (GIST) Treatment Market Outlook:
   1. Key Highlights
   2. Historical Market Size (US$ Mn) Analysis, By Market, 2020 - 2024
      1. By Country
      2. By Drug
      3. By Treatment Type
      4. By Services
      5. By Distribution Channel
   3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2026 - 2033
      1. China
      2. Japan
      3. South Korea
   4. Market Size (US$ Mn) Analysis and Forecast, By Drug, 2026 - 2033
      1. Imatinib
      2. Ripretinib
      3. Crenolanib
      4. Regorafenib
      5. Avapritinib
      6. Sunitinib
      7. Others
   5. Market Size (US$ Mn) Analysis and Forecast, By Treatment Type, 2026 - 2033
      1. Targeted Therapy
      2. Immunotherapy
      3. Chemotherapy
      4. Surgery
   6. Market Size (US$ Mn) Analysis and Forecast, By Distribution Channel, 2026 - 2033
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
   7. Market Attractiveness Analysis
9. South Asia & Oceania Gastrointestinal Stromal Tumor (GIST) Treatment Market Outlook:
   1. Key Highlights
   2. Historical Market Size (US$ Mn) Analysis, By Market, 2020 - 2024
      1. By Country
      2. By Drug
      3. By Treatment Type
      4. By Services
      5. By Distribution Channel
   3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2026 - 2033
      1. India
      2. Southeast Asia
      3. ANZ
      4. Rest of South Asia & Oceania
   4. Market Size (US$ Mn) Analysis and Forecast, By Drug, 2026 - 2033
      1. Imatinib
      2. Ripretinib
      3. Crenolanib
      4. Regorafenib
      5. Avapritinib
      6. Sunitinib
      7. Others
   5. Market Size (US$ Mn) Analysis and Forecast, By Treatment Type, 2026 - 2033
      1. Targeted Therapy
      2. Immunotherapy
      3. Chemotherapy
      4. Surgery
   6. Market Size (US$ Mn) Analysis and Forecast, By Distribution Channel, 2026 - 2033
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
   7. Market Attractiveness Analysis
10. Latin America Gastrointestinal Stromal Tumor (GIST) Treatment Market Outlook:
    1. Key Highlights
    2. Historical Market Size (US$ Mn) Analysis, By Market, 2020 - 2024
       1. By Country
       2. By Drug
       3. By Treatment Type
       4. By Services
       5. By Distribution Channel
    3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2026 - 2033
       1. Brazil
       2. Mexico
       3. Rest of Latin America
    4. Market Size (US$ Mn) Analysis and Forecast, By Drug, 2026 - 2033
       1. Imatinib
       2. Ripretinib
       3. Crenolanib
       4. Regorafenib
       5. Avapritinib
       6. Sunitinib
       7. Others
    5. Market Size (US$ Mn) Analysis and Forecast, By Treatment Type, 2026 - 2033
       1. Targeted Therapy
       2. Immunotherapy
       3. Chemotherapy
       4. Surgery
    6. Market Size (US$ Mn) Analysis and Forecast, By Distribution Channel, 2026 - 2033
       1. Hospital Pharmacies
       2. Retail Pharmacies
       3. Online Pharmacies
    7. Market Attractiveness Analysis
11. Middle East & Africa Gastrointestinal Stromal Tumor (GIST) Treatment Market Outlook:
    1. Key Highlights
    2. Historical Market Size (US$ Mn) Analysis, By Market, 2020 - 2024
       1. By Country
       2. By Drug
       3. By Treatment Type
       4. By Services
       5. By Distribution Channel
    3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2026 - 2033
       1. GCC Countries
       2. Egypt
       3. South Africa
       4. Northern Africa
       5. Rest of Middle East & Africa
    4. Market Size (US$ Mn) Analysis and Forecast, By Drug, 2026 - 2033
       1. Imatinib
       2. Ripretinib
       3. Crenolanib
       4. Regorafenib
       5. Avapritinib
       6. Sunitinib
       7. Others
    5. Market Size (US$ Mn) Analysis and Forecast, By Treatment Type, 2026 - 2033
       1. Targeted Therapy
       2. Immunotherapy
       3. Chemotherapy
       4. Surgery
    6. Market Size (US$ Mn) Analysis and Forecast, By Distribution Channel, 2026 - 2033
       1. Hospital Pharmacies
       2. Retail Pharmacies
       3. Online Pharmacies
    7. Market Attractiveness Analysis
12. Competition Landscape
    1. Market Share Analysis, 2024
    2. Market Structure
       1. Competition Intensity Mapping By Market
       2. Competition Dashboard
    3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
       1. Novartis
          1. Overview
          2. Segments and Products
          3. Key Financials
          4. Market Developments
          5. Market Strategy
       2. Pfizer
       3. Bayer AG
       4. Deciphera Pharmaceuticals
       5. Blueprint Medicines
       6. Taiho Pharmaceutical
       7. Daiichi Sankyo
       8. Roche
       9. Bristol-Myers Squibb
       10. Others
13. Appendix
    1. Research Methodology
    2. Research Assumptions
    3. Acronyms and Abbreviations